(Q37742364)

22 August 2017

1 reference

title

HDL and atherosclerosis: an update (English)

1 reference

22 August 2017

1 reference

Gwynne JT

1

1 reference

22 August 2017

publication date

1 February 1991

1 reference

22 August 2017

1 reference

22 August 2017

volume

14

1 reference

22 August 2017

issue

2 Suppl 1

1 reference

22 August 2017

page(s)

I17-24

1 reference

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Multivariate analysis of the twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study and the usefulness of high density lipoprotein cholesterol percentage

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

HDL serum cholesterol and 24-year mortality of men in Finland.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

High-density-lipoprotein cholesterol in the Maasai of East Africa: a cautionary note

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Tangier disease: a disorder of intracellular membrane traffic

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Apolipoprotein A-IMilano. Correlation between high density lipoprotein subclass distribution and triglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Plasma lipoproteins in familial hepatic lipase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Review of lipid-lowering clinical trials in relation to observational epidemiologic studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Hydrolysis of human plasma high density lipoprotein2-phospholipids and triglycerides by hepatic lipase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Relationship in adipose cells between the presence of receptor sites for high density lipoproteins and the promotion of reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

The effect of dietary changes on high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: therapeutic approaches to prevention of atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Management of the patient with a low HDL-cholesterol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141303

7 January 2021

Identifiers

DOI

10.1002/CLC.4960141303

0 references

1 reference